SUN PHARMACEUTICAL IND L vs Vivo Bio Tech Ltd

A side-by-side comparison of SUN PHARMACEUTICAL IND L (SUNPHARMA) and Vivo Bio Tech Ltd (VIVOBIOTECHLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, SUN PHARMACEUTICAL IND L leads SUNPHARMA vs VIVOBIOTECHLTD on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth10
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

40.39
P/E ratio
-15.60
20.07
P/B ratio
0.49
0.84%
Dividend yield
0.00%
₹47.84
EPS
₹-0.77

Profitability

SUNPHARMA takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.00%
Return on equity
-2.00%
21.00%
Return on capital
7.29%
30.00%
EBITDA margin
39.10%
19.69%
Net margin
-3.21%

Growth

SUNPHARMA takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.03%
Revenue CAGR (3Y)
0.70%
10.57%
Profit CAGR (3Y) even

Size & financial health

SUNPHARMA takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.63L Cr
Market cap
₹45 Cr
₹58,462 Cr
Revenue
₹53 Cr
₹11,509 Cr
Net profit
₹-2 Cr
0.61
Debt / equity
0.72
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
Vivo Bio Tech Ltd
  • + ["Stock is trading at 0.48 times its book value"]
  • ["Company has low interest coverage ratio.", "Promoter holding has decreased over last quarter: -4.81%", "The company has delivered a poor sales growth of 0.59% over past five years.", "Promoter holding is low: 30.6%", "Company has a low return on equity of 2.24% over last 3 years."]
SUN PHARMACEUTICAL IND L full analysis Vivo Bio Tech Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.